ONCO
Onconetix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.02
+38.02%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-31.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 22, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 49,710 | $0.69 |
| Apr 21, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 53,867 | $0.73 |
| Apr 21, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 94,462 | $0.75 |
| Apr 21, 2026 | HRT FINANCIAL LP · 10 percent owner | Purchase | 34,636 | $0.73 |
| Apr 16, 2026 | HRT FINANCIAL LP · 10 percent owner | Purchase | 92,554 | $0.76 |
| Apr 16, 2026 | HRT FINANCIAL LP · 10 percent owner | Purchase | 74,350 | $0.77 |
| Aug 19, 2025 | Oakley Andrew John · director | A-Award | 618 | $0.00 |
| Aug 19, 2025 | Tarsh Simon · director | A-Award | 618 | $0.00 |
| Aug 19, 2025 | Meier Thomas · director | A-Award | 618 | $0.00 |
| Aug 19, 2025 | Ramdeen Timothy R. · director | A-Award | 618 | $0.00 |
| Mar 25, 2025 | Oakley Andrew John · director | A-Award | 1,709 | $0.00 |
| Jan 22, 2025 | Schiess Ralph · officer: Interim CEO, CSO | A-Award | 177,462 | $0.00 |
| Jan 22, 2025 | Bruhlmann Christian · officer: Chief Strategy Officer | A-Award | 177,462 | $0.00 |
| Sep 30, 2024 | SINGH AJIT · director | A-Award | 3,318 | $0.00 |
| Sep 30, 2024 | Tarsh Simon · director | A-Award | 3,318 | $0.00 |
| Sep 30, 2024 | SAPIRSTEIN JAMES · director | A-Award | 3,318 | $0.00 |
| Sep 30, 2024 | Meier Thomas · director | A-Award | 3,318 | $0.00 |
| Sep 30, 2024 | Ramdeen Timothy R. · director | A-Award | 3,318 | $0.00 |
| Sep 26, 2024 | Schiess Ralph · officer: Interim CEO & CSO | A-Award | 489,160 | $0.00 |
| Sep 26, 2024 | Bruhlmann Christian · officer: Chief Strategy Officer | A-Award | 428,010 | $0.00 |
| Feb 21, 2024 | SINGH AJIT · director | A-Award | 3,125 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 0Reduced 0Sold out 5
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | New Position | 11,854 | May 15, 2026 |
| CITIGROUP INC | New Position | 1,717 | May 11, 2026 |
| UBS GROUP AG | New Position | 1,580 | May 5, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | New Position | 1,454 | May 15, 2026 |
| SBI SECURITIES CO., LTD. | New Position | 120 | Apr 28, 2026 |
| SBI Securities Co., Ltd. | Sold Out | 0 | Apr 28, 2026 |
| CITIGROUP INC | Sold Out | 0 | May 11, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| Tower Research Capital LLC (TRC) | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 22, 2026